Skip to main content

Irene De la Calle Fuentes

Institutions of which they are part

Predoctoral researcher
Biomedical Research in Gynaecology
Vall Hebron Institut de Recerca

Irene De la Calle Fuentes

Institutions of which they are part

Predoctoral researcher
Biomedical Research in Gynaecology
Vall Hebron Institut de Recerca

Projects

Recerca biomèdica en ginecologia

IP: Antonio Gil Moreno
Collaborators: Natalia Rodriguez Gómez - Hidalgo, Elena Suarez Salvador, Jose Luis Poza Barrasus, Vicente Bebia Conesa, Angel García Jiménez, Maria Asuncion Perez Benavente, Carina Masferrer Ferragutcasas, Eva Colas Ortega, Sabina Salicrú Riera, Anna Ruano Lopez, Fco Javier De la Torre Fdez de Vega, Montserrat Cubo Abert, Silvia Cabrera Diaz, Laura Mañalich Barrachina, Marta Rebull Santamaria, Ana Luzarraga Aznar, Irene De la Calle Fuentes, Melissa Bradbury Lobato, Recerca biomèdica en ginecologia, Melek Denizli
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 40000
Reference: 2021 SGR 01157
Duration: 01/01/2022 - 30/06/2025

Cytomark - Desarrollo de un test diagnóstico personalizado y no invasivo de cáncer de endometrio en el fluido cervical

IP: Eva Colas Ortega
Collaborators: Vicente Bebia Conesa, Angel García Jiménez, Carina Masferrer Ferragutcasas, Silvia Cabrera Diaz, Antonio Gil Moreno, Marta Rebull Santamaria, Ana Luzarraga Aznar, Irene De la Calle Fuentes, Raquel Delgado Gil, Cytomark - Desarrollo de un test diagnóstico personalizado y no invasivo de cáncer de endometrio en el fluido cervical, Melek Denizli , Valeria Tubita
Funding agency: Asociación Española Contra el Cáncer
Funding: 188000
Reference: PERME212443COLA
Duration: 01/01/2022 - 31/01/2026

ADVANCING ON THE DEVELOPMENT OF A NON-INVASIVE TOOL TO EARLY DIAGNOSE ENDOMETRIAL CANCER

IP: Eva Colas Ortega
Collaborators: Carina Masferrer Ferragutcasas, Fco Javier De la Torre Fdez de Vega, Silvia Cabrera Diaz, Anabel Montero Armengol, Irene De la Calle Fuentes, ADVANCING ON THE DEVELOPMENT OF A NON-INVASIVE TOOL TO EARLY DIAGNOSE ENDOMETRIAL CANCER
Funding agency: Instituto de Salud Carlos III
Funding: 135520
Reference: PI20/00644
Duration: 01/01/2021 - 31/12/2024

Targeting the most aggressive type of endometrial carcinoma

IP: Antonio Gil Moreno
Collaborators: Carina Masferrer Ferragutcasas, Marta Rebull Santamaria, Irene De la Calle Fuentes, Melissa Bradbury Lobato, Raquel Delgado Gil, Targeting the most aggressive type of endometrial carcinoma, Melek Denizli
Funding agency: Asociación Española Contra el Cáncer
Funding: 199250
Reference: GCTRA18014MATI
Duration: 18/02/2019 - 31/10/2024

Related news

The Biomedical Research in Gynaecology group at VHIR has contributed to this international resource with endometrial cancer organoid models.

The ten groups within the Cancer Area combine basic, translational and clinical research to identify new targets, biomarkers and therapeutic strategies

The study evaluated the results of combining SYD985, a HER2 antibody conjugated to a potent cytotoxic drug, and niraparib, an inhibitor of DNA damage repair.

Related professionals

Noelia Luengo Alvarez

Noelia Luengo Alvarez

Research assistant
Donation and transplantation of organs, tissues and cells
Read more
Rocio Lecegui Alfonso

Rocio Lecegui Alfonso

Administration and Management
Growth and Development
Read more
Pablo Gabriel Medina

Pablo Gabriel Medina

Predoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Read more
Sandra  Banderas García

Sandra Banderas García

Ophtalmology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.